SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment

DRUG2 trials

Sponsors

DFB Soria, LLC

Conditions

Actinic KeratosisCervical Intraepithelial Neoplasia

Phase 2

Study of SOR007 Ointment for Actinic Keratosis

CompletedNCT03083470

DFB Soria, LLCActinic Keratosis

Start: 2017-05-18End: 2018-03-12Updated: 2019-05-15

Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)

WithdrawnNCT03143491

DFB Soria, LLCCervical Intraepithelial Neoplasia

Start: 2017-10-01End: 2019-03-01Updated: 2017-10-18

Related Papers

Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer

Breast Cancer Research and Treatment2022-04-268 citations